Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: BMS To Tap Early-Stage Breakthroughs In Partnership With BioMotiv

Sep 06 2019

• By Joseph Haas and Sten Stovall

DealWatch_1200x675

Related Content

Video: Interview With Baiju Shah Of BioMotiv

Sep 28 2015

Sandoz And Polpharma Strike Global Deal For Natalizumab

Sep 04 2019

Mylan Gets Until April 2020 To Decide On Biosimilar Botox Collaboration With Revance

Sep 04 2019

Video: Chris Viehbacher Interviewed At BioPharm America

Sep 24 2015

Novartis Dives Into Inflammasome Pool With IFM Tre Purchase

Apr 01 2019

Vertex Buys Semma, Gaining Cell Therapy-Based Type 1 Diabetes Treatments

Sep 03 2019

Boehringer Ingelheim Snaps Up Lupin's MEK Inhibitor For Difficult-To-Treat Cancers

Sep 04 2019

Cidara's Once-Weekly Antifungal Gets Phase III Boost From Mundipharma

Sep 05 2019

ANI Pharma Looks to Buy A Platform For Its Push Into Injectables

Sep 02 2019

Celltrion Enlists Lonza To Help Make Its Remsima

Sep 05 2019

KemPharm Plans To License Out Commercial Rights For Pain, ADHD Candidates

Nov 18 2017

Roche $4.8bn Buy Sparks Hemophilia Gene Therapy Race

Feb 25 2019

Roche’s Pipeline Prospects Promise Steady Sailing To More Growth

Aug 01 2019

Zogenix To Pay $250m Upfront To Buy Modis For Ultra-Orphan Drug

Aug 27 2019

GSK Opts In On Ionis’ Antisense Candidates For Hep B

Aug 27 2019

Despite BMS Bid, Celgene Pays $75m Upfront For Immatics Assets Options

Aug 28 2019

Amgen's $13.4bn Otezla Buy Helps Bristol/Celgene Merger Close By Year-End

Aug 27 2019

Related Companies

Bristol Myers Squibb Company

BioMotiv, LLC

University Hospitals

Takeda Pharmaceutical Co. Ltd.

Biogen, Inc.

IFM Tre

IFM Tre

Novartis AG

Zevra Therapeutics, Inc.

Sanofi

Roche Holding AG

Spark Therapeutics, Inc.

Johnson & Johnson

PharmaMar, S.A.

Otsuka Holdings Co., Ltd.

MOD3 Pharma

Cara Therapeutics, Inc.

Mundipharma International Limited

Cidara Therapeutics, Inc.

Lonza Group AG

Celltrion, Inc.

Boehringer Ingelheim GmbH

Lupin Limited

Polpharma SA

Novartis AG

Revance Therapeutics, Inc.

Viatris Inc.

Semma Therapeutics

ANI Pharmaceuticals, Inc.

Bristol Myers Squibb Company

Immatics N.V.

Ionis Pharmaceuticals, Inc.

Zogenix, Inc.

Additional Topics

Deals Business Strategies Commercial M & A BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window